ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 1,346.00
+3.00 (0.22%)
At close: Nov 6, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 36.28 billion as of November 5, 2026. It is the 34,530th most valuable company in the world and the 1,992nd biggest in South Korea. Its market cap has decreased by 22.12% in one year.
Market Cap
36.28B
Enterprise Value
34.48B
Revenue
12.57B
Global Rank
Country Rank
#1,992 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 36.28B, an increase of 43.12%. That is a compound annual growth rate of 5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 36.28B | 9.22% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IMGT Co.,Ltd. | 57.66B |
| TegoScience | 55.65B |
| PanGen Biotech | 55.54B |
| NovMetaPharma | 53.10B |
| KoBioLabs | 51.56B |
| Psomagen | 51.36B |
| Epibiotech | 48.44B |
| QuadMedicine | 46.85B |